Large porous particle impingement on lung epithelial cell monolayers--toward improved particle characterization in the lung.
OBJECTIVE
The ability to optimize new formulations for pulmonary delivery has been limited by inadequate in vitro models used to mimic conditions particles encounter in the lungs. The aim is to develop a physiologically-relevant model of the pulmonary epithelial barrier that would allow for quantitative characterization of therapeutic aerosols in vitro.


METHODS
Calu-3 human bronchial epithelial cells were cultured on permeable filter inserts under air-interfaced culture (AIC) and liquid-covered culture (LCC) conditions. Calu-3 cells grown under both conditions formed tight monolayers and appeared physiologically similar by SEM and immunocytochemical staining against cell junctional proteins and prosurfactant protein-C.


RESULTS
Aerosolized large porous particles (LPP) deposited homogeneously and reproducibly on the cell surface and caused no apparent damage to cell monolayers by SEM and light microscopy. However, monolayers initially grown under LCC conditions showed a significant decrease in barrier properties within the first 90 min after impingement with microparticles, as determined by transepithelial electrical resistance (TEER) measurements and fluorescein-sodium transport. Conversely, AIC grown monolayers showed no significant change in barrier properties within the first 90 min following particle application. A dense mucus coating was found on AIC grown Calu-3 monolayers, but not on LCC grown monolayers, which may protect the cell surface during particle impinging.


CONCLUSIONS
This in vitro model, based on AIC grown Calu-3 cells, should allow a more relevant and quantitative characterization of therapeutic aerosol particles intended for delivery to the tracheobronchial region of the lung or to the nasal passages. Such characterization is likely to be particularly important with therapeutic aerosol particles designed to provide sustained drug release in the lung.
Department of Chemical & Biomolecular Engineering, The Johns Hopkins University, 3400 N. Charles Street, Baltimore, Maryland 21218, USA.
Jennifer
J
Fiegel
Carsten
C
Ehrhardt
Ulrich Friedrich
UF
Schaefer
Claus-Michael
CM
Lehr
Justin
J
Hanes
D000336:Aerosols / Q000008:administration & dosage* / Q000493:pharmacokinetics; D045744:Cell Line, Tumor / Q000187:drug effects / Q000378:metabolism; D016503:Drug Delivery Systems / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D008168:Lung / Q000187:drug effects / Q000378:metabolism*; D010316:Particle Size; D016062:Porosity; D020545:Respiratory Mucosa / Q000187:drug effects / Q000378:metabolism*
D000336:Aerosols